Fuss Brands Corp. - Understand $fbds stock

$FBDS Market Cap: $20 Thousand

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$0.00

TTM

Gross Margin

Net Earnings

-$2.869M

TTM

Current Assets

$236.7K

Q3 2024

Current Liabilities

$895.1K

Q3 2024

Current Ratio

26.44%

Q3 2024

Total Assets

$236.7K

Q3 2024

Total Liabilities

$895.1K

Q3 2024

Book Value

-$658.4K

Q3 2024

Cash

$9.007K

Q3 2024

P/E

-0.006971

Nov 11, 2024 EST

Free Cash Flow

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998
Revenue			$0.00	$0.00	$72.71M	$55.18M	$43.41M	$34.47M	$28.04M	$0.00	$0.00	$0.00	$57.84M	$26.27M	$10.99M	$4.690M	$3.550M
YoY Change					31.77%	27.11%	25.94%	22.93%				-100.0%	120.18%	139.04%	134.33%	32.11%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2021	2020	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999
Revenue	$0.00	$0.00	$72.71M	$55.18M	$43.41M	$34.47M	$28.04M	$0.00	$0.00	$0.00	$57.84M	$26.27M	$10.99M	$4.690M	$3.550M
Cost Of Revenue			$29.53M	$25.77M	$20.31M	$15.98M	$13.69M				$43.21M	$17.70M	$7.530M	$3.410M	$2.300M
Gross Profit			$43.18M	$29.42M	$23.10M	$18.49M	$14.35M				$14.63M	$8.570M	$3.460M	$1.280M	$1.250M
Gross Profit Margin			59.39%	53.32%	53.21%	53.64%	51.18%				25.29%	32.62%	31.48%	27.29%	35.21%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999
Selling, General & Admin	$503.1K	$107.4K	$330.0K	$0.00	$10.07M	$8.580M	$5.770M	$6.200M	$3.740M				$13.35M	$8.730M	$6.720M	$3.060M	$1.300M
YoY Change	368.37%	-67.45%			17.37%	48.7%	-6.94%	65.78%					52.92%	29.91%	119.61%	135.38%
% of Gross Profit					23.32%	29.16%	24.98%	33.53%	26.06%				91.25%	101.87%	194.22%	239.06%	104.0%
Research & Development					$3.590M	$3.040M	$2.530M	$2.120M	$280.0K
YoY Change					18.09%	20.16%	19.34%	657.14%
% of Gross Profit					8.31%	10.33%	10.95%	11.47%	1.95%
Depreciation & Amortization					$950.0K	$800.0K	$360.0K	$340.0K	$290.0K	$70.00K	$90.00K	$90.00K	$50.00K	$30.00K	$390.0K	$130.0K	$0.00
YoY Change					18.75%	122.22%	5.88%	17.24%	314.29%	-22.22%	0.0%	80.0%	66.67%	-92.31%	200.0%
% of Gross Profit					2.2%	2.72%	1.56%	1.84%	2.02%				0.34%	0.35%	11.27%	10.16%	0.0%
Operating Expenses	$503.1K	$107.4K	$330.0K		$13.66M	$11.62M	$8.300M	$8.320M	$4.320M				$13.35M	$8.730M	$6.720M	$3.060M	$1.310M
YoY Change	368.37%	-67.45%			17.56%	40.0%	-0.24%	92.59%					52.92%	29.91%	119.61%	133.59%
Operating Profit	-$503.1K	-$107.4K	-$325.1K		$29.52M	$17.80M	$14.80M	$10.17M	$10.03M				$1.280M	-$160.0K	-$3.260M	-$1.780M	-$60.00K
YoY Change	368.37%	-66.96%			65.84%	20.27%	45.53%	1.4%					-900.0%	-95.09%	83.15%	2866.67%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2020	2011	2010	2009	2008	2007	2003	2002	2001	2000	1999
Interest Expense	$2.119K		$130.0K	$70.00K	$40.00K	$90.00K		-$150.0K	-$180.0K	-$200.0K	-$30.00K
YoY Change			85.71%	75.0%	-55.56%			-16.67%	-10.0%	566.67%
% of Operating Profit			0.44%	0.39%	0.27%	0.88%		-11.72%
Other Income/Expense, Net		$0.00			$0.00	$30.00K	$40.00K	-$30.00K	$40.00K	$30.00K	$10.00K	$0.00
YoY Change					-100.0%	-25.0%		-175.0%	33.33%	200.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999
Pretax Income	-$505.2K	-$107.4K	-$330.0K	$0.00	$29.65M	$17.87M	$14.85M	$10.29M	$9.600M				$740.0K	-$460.0K	-$6.570M	-$1.800M	-$60.00K
YoY Change	370.34%	-67.45%			65.92%	20.34%	44.31%	7.19%					-260.87%	-93.0%	265.0%	2900.0%
Income Tax				$0.00	$3.730M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
% Of Pretax Income					12.58%	0.0%	0.0%	0.0%	0.0%				0.0%
Net Earnings	-$505.2K	-$107.4K	-$330.0K		$25.92M	$17.87M	$14.85M	$10.29M	$9.600M	$880.0K	-$3.450M	-$1.120M	$900.0K	-$440.0K	-$6.570M	-$1.800M	-$60.00K
YoY Change	370.34%	-67.45%			45.05%	20.34%	44.31%	7.19%	990.91%	-125.51%	208.04%	-224.44%	-304.55%	-93.3%	265.0%	2900.0%
Net Earnings / Revenue					35.65%	32.38%	34.21%	29.85%	34.24%				1.56%	-1.67%	-59.78%	-38.38%	-1.69%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.03	-$0.01	-$230.8K	$0.00	$17.88M	$11.53M	$10.68M	$7.622M	$7.111M	$88.00M	-$345.0M	-$112.0M	$90.00M	-$195.7M	-$4.711B	-$3.410B	-$124.8M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998
Cash & Short-Term Investments	$9.450K	$35.54K			$15.30M	$27.80M	$8.100M	$9.700M	$10.20M	$1.000M	$2.400M	$2.200M	$2.800M	$700.0K	$100.0K	$300.0K	$100.0K	$100.0K
YoY Change	-73.41%				-44.96%	243.21%	-16.49%	-4.9%	920.0%	-58.33%	9.09%	-21.43%	300.0%	600.0%	-66.67%	200.0%	0.0%
Cash & Equivalents		$35.54K			$15.30M	$27.80M	$8.100M	$9.700M	$10.20M	$1.000M	$1.300M	$2.200M	$2.800M	$700.0K	$100.0K	$300.0K	$100.0K	$100.0K
Short-Term Investments											$1.100M	$1.100M
Other Short-Term Assets	$129.9K						$100.0K	$0.00	$0.00	$200.0K	$5.900M	$3.700M	$7.600M	$1.200M	$500.0K	$100.0K	$0.00	$0.00
YoY Change									-100.0%	-96.61%	59.46%	-51.32%	533.33%	140.0%	400.0%
Inventory					$7.400M	$2.600M	$3.000M	$2.600M	$1.000M	$600.0K
Prepaid Expenses
Receivables					$21.50M	$19.80M	$23.20M	$20.80M	$10.50M	$7.600M	$1.200M	$2.000M	$2.500M	$1.300M	$500.0K	$300.0K	$100.0K	$100.0K
Other Receivables					$6.900M	$200.0K	$200.0K	$200.0K	$700.0K	$1.100M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$100.0K	$100.0K
Total Short-Term Assets	$139.4K	$35.54K			$51.10M	$50.50M	$34.70M	$33.40M	$22.30M	$10.60M	$9.500M	$7.900M	$12.90M	$3.200M	$1.100M	$700.0K	$300.0K	$300.0K
YoY Change	292.15%				1.19%	45.53%	3.89%	49.78%	110.38%	11.58%	20.25%	-38.76%	303.13%	190.91%	57.14%	133.33%	0.0%
Property, Plant & Equipment					$3.700M	$2.100M	$2.400M	$2.600M	$2.600M	$2.700M	$200.0K	$200.0K	$300.0K	$100.0K	$100.0K	$200.0K	$0.00	$0.00
YoY Change					76.19%	-12.5%	-7.69%	0.0%	-3.7%	1250.0%	0.0%	-33.33%	200.0%	0.0%	-50.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00		$0.00	$0.00	$38.00M	$18.60M	$16.10M	$0.00			$0.00	$100.0K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change					104.3%	15.53%					-100.0%
Total Long-Term Assets	-$10.00	$0.00			$58.80M	$22.60M	$18.50M	$2.600M	$2.600M	$2.700M	$300.0K	$400.0K	$400.0K	$600.0K	$500.0K	$4.200M	$100.0K	$100.0K
YoY Change					160.18%	22.16%	611.54%	0.0%	-3.7%	800.0%	-25.0%	0.0%	-33.33%	20.0%	-88.1%	4100.0%	0.0%
Total Assets	$139.4K	$35.54K	$0.00	$0.00	$109.9M	$73.10M	$53.20M	$36.00M	$24.90M	$13.30M	$9.800M	$8.300M	$13.30M	$3.800M	$1.600M	$4.900M	$400.0K	$400.0K
YoY Change
Accounts Payable	$106.0K	$1.050K			$2.100M	$300.0K	$400.0K	$200.0K	$200.0K	$800.0K	$100.0K	$200.0K	$500.0K	$200.0K	$500.0K	$300.0K	$0.00	$0.00
YoY Change	9994.29%				600.0%	-25.0%	100.0%	0.0%	-75.0%	700.0%	-50.0%	-60.0%	150.0%	-60.0%	66.67%
Accrued Expenses	$157.0K				$8.100M	$2.700M	$2.300M	$1.400M			$1.600M	$1.000M	$500.0K	$200.0K	$200.0K	$300.0K	$100.0K	$100.0K
YoY Change					200.0%	17.39%	64.29%				60.0%	100.0%	150.0%	0.0%	-33.33%	200.0%	0.0%
Deferred Revenue
YoY Change
Short-Term Debt	$98.38K	$98.38K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$5.900M	$3.600M	$7.500M	$1.300M	$300.0K	$2.800M	$300.0K	$300.0K
YoY Change	0.0%									-100.0%	63.89%	-52.0%	476.92%	333.33%	-89.29%	833.33%	0.0%
Long-Term Debt Due	$50.00K
YoY Change
Total Short-Term Liabilities	$588.0K	$99.43K	$0.00	$0.00	$10.20M	$3.400M	$2.700M	$2.000M	$3.500M	$2.700M	$9.600M	$7.800M	$11.40M	$2.900M	$1.500M	$3.500M	$400.0K	$400.0K
YoY Change	491.38%				200.0%	25.93%	35.0%	-42.86%	29.63%	-71.88%	23.08%	-31.58%	293.1%	93.33%	-57.14%	775.0%	0.0%
Long-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$100.0K	$0.00	$0.00	$300.0K	$1.200M	$0.00	$0.00	$0.00
YoY Change										-100.0%			-100.0%	-75.0%
Other Long-Term Liabilities	$0.00	$0.00	$0.00	$0.00										$100.0K	$100.0K	$100.0K	$0.00	$0.00
YoY Change														0.0%	0.0%
Total Long-Term Liabilities	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$100.0K	$0.00	$0.00	$400.0K	$1.300M	$100.0K	$0.00	$0.00
YoY Change										-100.0%			-100.0%	-69.23%	1200.0%
Total Liabilities	$588.0K	$99.43K	$0.00	$0.00	$10.20M	$3.400M	$2.700M	$2.000M	$3.500M	$2.700M	$9.700M	$7.800M	$11.40M	$3.300M	$2.800M	$3.600M	$400.0K	$400.0K
YoY Change	491.38%				200.0%	25.93%	35.0%	-42.86%	29.63%	-72.16%	24.36%	-31.58%	245.45%	17.86%	-22.22%	800.0%	0.0%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $20 Thousand

About Fuss Brands Corp.

Fuss Brands Corp. engages in the research, manufacture and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines. The company is headquartered in New York City, New York and currently employs 1 full-time employees. The company went IPO on 2013-06-07. The firm has marketing and distribution rights for a patented range of luggage that provides a regulation-size carry-on bag into a full-sized suitcase as well as a compact and handy laptop bag that will be a preferred travel and day-to-day companion for businesspeople and students alike.

Industry: Pharmaceutical Preparations Peers: Safety Shot, Inc. INTEGRATED BIOPHARMA INC CYANOTECH CORP MAKINGORG, INC. ESTEE LAUDER COMPANIES INC High Sierra Technologies, Inc. Zivo Bioscience, Inc. TWINLAB CONSOLIDATED HOLDINGS, INC. NUTRALIFE BIOSCIENCES, INC